ESMO Announces Merit Award Recipients at ESMO Breast Cancer 2026
Recognition
The European Society for Medical Oncology (ESMO) has announced the recipients of the ESMO Breast Cancer 2026 Merit Awards, recognizing first authors whose submitted abstracts were considered especially deserving of distinction at this year’s congress.
Commitment
This award is presented as part of ESMO’s ongoing commitment to supporting the next generation of oncology leaders, highlighting investigators contributing meaningful scientific work to the evolving landscape of breast cancer research.
Awardees
- Milana Arantza Bergamino, Barcelona, Spain
- Emily Berry, London, United Kingdom
- Giacomo Biganzoli, Milan, Italy
- Agostino Bucalo, Rome, Italy
- Renata Colombo Bonadio, São Paulo, Brazil
- Niamh Cunningham, London, United Kingdom
- Frederick Matthew Howard, Chicago, United States
- Flavia Jacobs, Milan, Italy
- Soraia Lobo-Martins, Brussels, Belgium
- Olga Martinez Saez, Barcelona, Spain
- Guilherme Nader Marta, Boston, United States
- Alejandra Rezqallah Aron, Barcelona, Spain
- Tommaso Ruelle, Genoa, Italy
- Paolo Tarantino, Boston, United States
- Carmine Valenza, Milan, Italy
- Karen Van Baelen, Leuven, Belgium
- Neelima Vidula, Boston, United States
- Guillermo Villacampa, Barcelona, Spain
Impact
The ESMO Merit Awards continue to serve as an important platform for highlighting promising investigators and impactful scientific work within the global oncology community. By recognizing early and mid-career researchers presenting at the congress, the initiative helps amplify innovative ideas and supports continued academic development in breast cancer research.
Future of Breast Oncology
As new treatment strategies and biomarker-driven approaches continue to redefine care, recognition programs like the Merit Awards underscore the importance of supporting scientific excellence across all stages of oncology research.
Resources
Find more exclusive oncology content on OncoDaily